Warp Drive Bio
And finally this week we have news from Warp Drive Bio, a life sciences company using proprietary genomic technology to transform the discovery and development of natural product drugs.
The firm has made three new appointments of “proven, renowned and tenacious drug discovery and development experts,” according to founding CEO, Alexis Borisy, who becomes Executive Chairman of the Board.
His position will be taken by Dr. Gregory Verdine (centre), who has over 25 years of experience in the field of drug discovery and development, including forming several biotech companies and being global consultants for Hoffmann-La Roche.
Furthermore, Dr. James Nichols (left) – former President and CEO of Resolvyx Pharmaceuticals – takes the role of chief operating officer, and Dr. Julian Adams (right) – currently president, research and development at Infinity Pharmaceuticals – has joined the Board of Directors.